Physician profile
Joshua Benham
NPI 1528406881
$2,149.55
in general payments reported to CMS, 2019-2025
32 companies · $497 in 2025
The $497 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $166 · 2021: $463 · 2022: $361 · 2023: $344 · 2024: $203 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.97 |
| Education | $103.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $401.70 | 2019-2022 | |
| Millicent US INC | $205.80 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Myriad Women'S Health, INC. | $203.73 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $130.30 | 2020-2025 | Myosure Tissue Removal Device, Aptima, Acessa Provu System |
| Astellas Pharma US INC | $115.34 | 2023-2025 | Veozah |
| Amgen INC. | $93.01 | 2021-2024 | Evenity, Prolia |
| Coopersurgical, INC. | $92.67 | 2021-2025 | Paragard T 380a |
| Therapeuticsmd, INC. | $75.33 | 2020-2021 | |
| Exact Sciences Corporation | $67.76 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $67.52 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $63.33 | 2021-2024 | |
| Organon LLC | $60.92 | 2022-2024 | |
| Medicem INC. | $59.94 | 2021-2022 | |
| Biogen, INC. | $54.97 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $54.48 | 2021-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $51.80 | 2021 | |
| Ethicon US, LLC | $35.21 | 2025 | Ethicon, Surgicel Nu-Knit, Vistaseal |
| Pfizer INC. | $31.39 | 2021-2022 | |
| Minerva Surgical, INC | $29.41 | 2025 | |
| Shield Therapeutics INC | $26.98 | 2025 | |
| Sage Therapeutics, LLC | $24.80 | 2022 | |
| Channel Medsystems, INC. | $21.53 | 2022 | |
| Medtronic, INC. | $21.14 | 2023 | Truclear |
| Avanos Medical | $21.03 | 2021 | |
| Davol INC. | $20.27 | 2022 | |
| Becton, Dickinson and Company | $20.12 | 2021 | |
| Merck Sharp & Dohme LLC | $18.80 | 2021 | |
| Octapharma USA, INC. | $18.75 | 2025 | Fibryga |
| Ascend Therapeutics US, LLC | $18.47 | 2021 | |
| Mylan Pharmaceuticals INC. | $14.94 | 2021 | |
| Aspira Women'S Health INC | $14.74 | 2022 | |
| Agile Therapeutics, INC. | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Benham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.